Find Clinical Trials & Studies

Visit the Research & Education Institute

ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

I'm Interested!

Please call
1-800-641-2422

ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects With Leiomyosarcoma (ARGSARC): A Randomized, Double Blind, Multi-Center Phase 3 Trial

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Sarcoma

Study Purpose

To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.

Principal Investigator
Ankit Mangla MD

Department/Division
Cancer (Bone Cartilage and Soft Tissue)

UH IRB: Pro00077153/ 24-660
StudyID: PLRS1723
ClinicalTrials.gov: NCT05712694

I'm Interested!

Please call
1-800-641-2422

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422